Tools
Tools
Macfarlane, Cara 
ORCID: https://orcid.org/0000-0001-8210-5823, Dean, Laura ORCID: https://orcid.org/0000-0002-4910-9707, Thomson, Rachael and Garner, Paul ORCID: https://orcid.org/0000-0002-0607-6941
(2019)
'Community drug distributors for mass drug administration in neglected tropical disease programmes: systematic review and analysis of policy documents'. Journal of Global Health, Vol 9, Issue 2.
![[img]](https://archive.lstmed.ac.uk/style/images/fileicons/text.png) |
Text
CDD review manuscript_Resubmitted2019 (clean).docx - Accepted Version Available under License Creative Commons Attribution. Download (275kB) |
|
|
Text
jogh-09-020414.pdf - Published Version Available under License Creative Commons Attribution. Download (754kB) | Preview |
Abstract
Background
Mass drug administration (MDA) programmes for neglected tropical diseases (NTDs) depend on voluntary community drug distributors (CDDs) to deliver drugs, and these volunteer schemes need regular training and supervision. NTD policy now includes integration of multiple disease programmes, but we are unsure if there is clarity in what is currently expected of CDDs and how they are managed. We therefore analysed World Health Organization (WHO) policy, strategy and implementation guidance, and select national NTD programme implementation plans.
Methods
Included are a) WHO global and WHO-Regional Office for Africa guidelines, strategies, operational manuals and meeting reports published between January 2007 to February 2018 that included policy and plans for CDDs; and b) national NTD programme master plans for Cameroon, Ghana, Liberia and Nigeria. For both review components, we examined the CDD responsibilities through a framework developed iteratively against the documents and prepared a narrative synthesis.
Results
Twenty WHO policy documents met the inclusion criteria. In the twelve global and eight regional documents, the CDD role was not explicitly or comprehensively defined. Three documents mentioned CDDs will distribute drugs; some mentioned health promotion, data handling and engagement in clinical care. Four WHO documents noted a need for CDD training or management, eight detailed some aspect of this, and one regional document provided a comprehensive overview. In the national plans, additional responsibilities included case management in two countries and transmission control in two countries. Every plan included training and supervision, but this was not always explicit, and details of the purpose and frequency varied. In all national plans, CDD motivation was identified as a challenge but not comprehensively addressed, although one document mentioned provision of bicycles.
Conclusions
WHO and national policies and plans assume CDDs will implement NTD programmes. However, there is almost no clear delineation of responsibilities, nor is there up-to-date practical guidance to guide managers. This ambiguity, in relation to the lack of explicit policies or programmatic guidance, probably impairs the effectiveness of NTD programmes.
Statistics
Actions (login required)
 |
Edit Item |